Wyzga Michael S (CIK 0001201256)

Latest company ownership

Shares held
10,108
Last filed at
Mar 2, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q2 2025Q4
Shares held
5,555
Last filed at
Jun 10, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q3 2025Q4
Shares held
1,500
Last filed at
Mar 27, 2014
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 18, 2023 Aug 22, 2023 X4 Pharmaceuticals, Inc Director Buy 91.3 +25,000 48.39% $29.9K
Feb 26, 2021 Mar 2, 2021 EXACT SCIENCES CORP Director Sell 5.0 -19,021 -88.15% $2.5M
Jul 31, 2019 Aug 2, 2019 EXACT SCIENCES CORP Director Sell 7.5 -5,000 -35.94% $589.7K
Feb 28, 2019 Mar 1, 2019 EXACT SCIENCES CORP Director Sell 36.3 -500 -5.49% $48K
Aug 28, 2018 Aug 30, 2018 EXACT SCIENCES CORP Director Sell 15.0 -2,468 -21.31% $184.7K
May 10, 2018 May 11, 2018 EXACT SCIENCES CORP Director Sell 7.5 -7,402 -40.28% $381.4K
Mar 25, 2014 Mar 27, 2014 Akebia Therapeutics, Inc. Director Buy 91.3 +1,500 100.00% $25.5K